Drugs Made In America Acquisition (DMAAU) Interest & Investment Income (2025)

Drugs Made In America Acquisition (DMAAU) reported Interest & Investment Income of $2.3 million for Q4 2025, down 5.96% quarter-over-quarter from $2.4 million in Q3 2025.

Drugs Made In America Acquisition (DMAAU) Interest & Investment Income (2025) Analysis & Trends

Drugs Made In America Acquisition has reported Interest & Investment Income for 1 years, with the latest figure at $2.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income changed N/A year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2025 stood at $8.8 million (changed N/A YoY), and the FY2025 full-year result was $8.8 million, changed N/A from the prior year.
  • Interest & Investment Income for Q4 2025 stood at $2.3 million, down from $2.4 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $2.4 million in Q3 2025, with the low at $1.6 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 4.30 Mn
2 Centurion Acquisition 312.80 Mn 312.80 Mn - 2.72 Mn
3 Berto Acquisition 312.16 Mn 312.16 Mn - 2.70 Mn
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - 2.98 Mn
5 Churchill Capital Corp IX 310.50 Mn 310.50 Mn - 2.65 Mn
6 WEN Acquisition 308.55 Mn 308.55 Mn - 2.97 Mn
7 Agriculture & Natural Solutions Acquisition 304.08 Mn 304.08 Mn - -
8 Bold Eagle Acquisition 274.25 Mn 274.25 Mn - 2.37 Mn
9 Soulpower Acquisition 265.04 Mn 265.04 Mn - 2.27 Mn
10 Drugs Made In America Acquisition - - - 2.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.30 Mn
Sep 30, 2025 2.45 Mn
Jun 30, 2025 2.42 Mn
Mar 31, 2025 1.59 Mn